Obezite ve Neudesin
Özet
Küresel bir salgın haline gelen obezite, sağlık sistemleri üzerinde ağır bir yük oluşturmakta ve araştırmalar bu durumun mekanizmalarını aydınlatmaya odaklanmaktadır. Bu bağlamda, "Membranla İlişkili Progesteron Reseptörü" (MAPR) ailesinin bir üyesi olan neudesin, nöral fonksiyonlar, enerji metabolizması ve tümörijenez süreçlerinde çok yönlü roller üstlenen kritik bir biyobelirteç olarak öne çıkmaktadır. Neudesin, merkezi sinir sisteminde nörotrofik aktivite sergileyerek nöronal farklılaşmayı desteklerken, hipotalamusta gıda alımını ve iştahı düzenleyen anoreksijenik bir faktör olarak işlev görür. Enerji metabolizması açısından neudesin, beyaz yağ dokusunda adipogenezi baskılayan negatif bir düzenleyicidir. Yapılan çalışmalar, neudesin eksikliğinin sempatik aktiviteyi artırarak kahverengi yağ dokusunda ısı üretimini ve enerji harcamasını yükselttiğini, böylece diyete bağlı obeziteye karşı direnç sağladığını göstermektedir. Ayrıca neudesin, MAPK ve PI3K sinyal yollarını aktive ederek çeşitli kanser türlerinde tümör oluşumunu ve invazivliği teşvik edebilmektedir. Sonuç olarak neudesin, hem obezite hem de kanser tedavisi için potansiyel ve stratejik bir hedef molekül olma özelliği taşımaktadır.
Obesity, which has become a global pandemic, poses a heavy burden on health systems, and research focuses on illuminating the mechanisms of this condition. In this context, neudesin, a member of the "Membrane-Associated Progesterone Receptor" (MAPR) family, stands out as a critical biomarker that plays multifaceted roles in neural functions, energy metabolism, and tumorigenesis. Neudesin promotes neuronal differentiation by exhibiting neurotrophic activity in the central nervous system and acts as an anorexigenic factor regulating food intake and appetite in the hypothalamus. In terms of energy metabolism, neudesin is a negative regulator that suppresses adipogenesis in white adipose tissue. Studies show that neudesin deficiency increases sympathetic activity, enhancing heat production and energy expenditure in brown adipose tissue, thereby providing resistance against diet-induced obesity. Additionally, neudesin can promote tumor formation and invasiveness in various types of cancer by activating MAPK and PI3K signaling pathways. Consequently, neudesin possesses the characteristic of being a potential and strategic target molecule for both obesity and cancer treatment.
Referanslar
WHO. Obesity and overweight. [Online]. (10/08/2022tarihinde https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight adresinden ulaşılmıştır.)
WHO. Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%), Turkey. [Online]. (10/08/2022tarihinde https://www.who.int/data/gho/data/indicators/indicator-details/GHO/hem-obesity-prevalence-in-non-pregnant-women-aged-15-49-years-bmi-30 adresinden ulaşılmıştır.)
Patel A, Krishna SG, Patel K, et al. Rising rates of severe obesity in adults younger than 50 correspond to rise in hospitalizations for non-malignant gastrointestinal disease. Dig Dis Sci. 2022; 10.1007/s10620-022-07589-3. doi:10.1007/s10620-022-07589-3.
Ward ZJ, Bleich SN, Long MW, Gortmaker SL. Association of body mass index with health care expenditures in the United States by age and sex. PLoS One. 2021;16(3):e0247307. Published 2021 Mar 24. doi:10.1371/journal.pone.0247307.
Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. N Engl J Med. 2019;381(25):2440-2450. doi:10.1056/NEJMsa1909301
Rondinone CM. Adipocyte-derived hormones, cytokines, and mediators. Endocrine. 2006;29,81–90. doi: 10.1385/endo:29:1:81.
Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013;9(2):191–200. doi: 10.5114/aoms.2013.33181.
Bray GA. Medical consequences of obesity. Journal of Clinical Endocrinology and Metabolism. 2004;89(6):2583-9. doi: 10.1210/jc.2004-0535.
Wiedmer P, Nogueiras R, Broglio F, et al. Ghrelin, obesity and diabetes. Nature Clinical Practice Endocrinology and Metabolism. 2007;3: 705–12. doi:10.1038/ncpendmet0625.
Türkiye Halk Sağlığı Kurumu. Obezite ve Diyabet Klinik Rehberi 2017. (10/08/2022 tarihinde www.thsk.gov.tr adresinden ulaşılmıştır.)
Kratochvilova H, Lacinova Z, Klouckova J, et al. Neudesin in obesity and type 2 diabetes mellitus: The effect of acute fasting and weight reducing interventions. Diabetes, Metab Syndr Obes Targets Ther 2019;12:423–30. doi: 10.2147/DMSO.S193259. eCollection 2019.
Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology and Therapeutics. 2013;138(1):103-141.doi:10.1016/j.pharmthera. 2012.12.007
Pandey A V., Flück CE. NADPH P450 oxidoreductase: Structure, function, and pathology of diseases. Pharmacology and Therapeutics.2013;138(2):229-254. doi:10.1016/j.pharmthera. 2013.01.010.
Mifsud W, Bateman A. Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain. Genome Biol. 2002;3(12):RESEARCH0068. doi:10.1186/gb-2002-3-12-research0068
Kimura I, Nakayama Y, Konishi M, et al. Functions of MAPR (membrane-associated progesterone receptor) family members as heme/steroid-binding proteins. Curr Protein Pept Sci. 2012;13(7):687-696. doi:10.2174/138920312804142110.
Ryu CS, Klein K, Zanger UM. Membrane Associated Progesterone Receptors: Promiscuous Proteins with Pleiotropic Functions - Focus on Interactions with Cytochromes P450. Front Pharmacol. 2017;8:159. doi:10.3389/fphar.2017.00159
Kimura I, Nakayama Y, Konishi M, et al. Neuferricin, a novel extracellular heme-binding protein, promotes neurogenesis. J Neurochem. 2010;112(5):1156-1167. doi: 10.1111/j.1471-4159. 2009.06522.x
Bruce A, Rybak AP. CYB5D2 requires heme-binding to regulate HeLa cell growth and confer survival from chemotherapeutic agents. PLoS One. 2014;9(1):e86435. doi:10.1371/journal.pone. 0086435
Kimura I, Yoshioka M, Konishi M, Miyake A, Itoh N. Neudesin, a novel secreted protein with a unique primary structure and neurotrophic activity. J Neurosci Res. 2005;79(3):287-294. doi:10.1002/jnr.20356
Ohta H, Konishi M, Kobayashi Y, et al. Deletion of the Neurotrophic Factor neudesin Prevents Diet-induced Obesity by Increased Sympathetic Activity. Sci Rep. 2015;5:10049. doi:10.1038/srep10049
Ohta H, Kimura I, Konishi M, Itoh N. Neudesin as a unique secreted protein with multi-functional roles in neural functions, energy metabolism, and tumorigenesis. Front Mol Biosci. 2015;2:24. doi:10.3389/fmolb.2015.00024
Byerly MS, Simon J, Lebihan-Duval E, Duclos MJ, Cogburn LA, Porter TE. Effects of BDNF, T3, and corticosterone on expression of the hypothalamic obesity gene network in vivo and in vitro. American journal of physiology. Regulatory, integrative and comparative physiology, 2009;296(4):R1180-R1189. doi: 10.1152/ajpregu.90813.2008
Byerly MS, Swanson RD, Semsarzadeh NN, et al. Identification of hypothalamic neuron-derived neurotrophic factor as a novel factor modulating appetite. American journal of physiology. Regulatory, integrative and comparative physiology. 2013;304(12):R1085-R1095. doi:10.1152/ajpregu.00368.2012
Byerly MS, Al Salayta M, Swanson RD, et al. Estrogen-related receptor β deletion modulates whole-body energy balance via estrogen-related receptor γ and attenuates neuropeptide Y gene expression. Eur J Neurosci. 2013;37(7):1033-1047. doi: 10.1111/ejn.12122
de Rijke CE, Jackson PJ, Garner KM, et al. Functional analysis of the Ala67Thr polymorphism in agouti related protein associated with anorexia nervosa and leanness. Biochem Pharmacol. 2005;70(2):308-316. doi: 10.1016/j.bcp.2005.04.033
Chen X, Ye H, Kuruvilla R, et al. A chemical-genetic approach to studying neurotrophin signaling. Neuron. 2005;46(1):13-21. doi: 10.1016/j.neuron.2005.03.009
Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011;12(11):722-734. doi:10.1038/nrm3198
Kimura I, Konishi M, Asaki T, et al. Neudesin, an extracellular heme-binding protein, suppresses adipogenesis in 3T3-L1 cells via the MAPK cascade. Biochem Biophys Res Commun. 2009;381(1):75-80. doi: 10.1016/j.bbrc.2009.02.011
Bishop AC, Ubersax JA, Petsch DT, et al. A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature. 2000;407(6802):395-401. doi: 10.1038/35030148
Han KH, Lee SH, Ha SA, et al. The functional and structural characterization of a novel oncogene GIG47 involved in the breast tumorigenesis. BMC Cancer. 2012; 12:274. doi:10.1186/1471-2407-12-274
Stefanska B, Cheishvili D, Suderman M, et al. Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets. Clin Cancer Res. 2014;20(12):3118-3132. doi: 10.1158/1078-0432.CCR-13-0283
